...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.
【24h】

Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.

机译:肥胖Zucker大鼠中肾血管紧张素II 2型受体被上调并介导坎地沙坦诱导的利尿/利尿。

获取原文
获取原文并翻译 | 示例

摘要

Recently, there has been a growing interest in studying the role of angiotensin II type-2 (AT(2)) receptor in renal/cardiovascular function in pathological conditions. The present study was designed to determine the functional role of the AT(2) receptors on natriuresis/diuresis and compare the level of the tubular AT(2) receptor expression in obese and lean Zucker rats (12 weeks old). Under anesthesia, candesartan (angiotensin II type 1 [AT(1)]-specific antagonist; 100 microg/kg bolus) produced natriuresis/diuresis to a greater degree in obese than in lean rats. The specific AT(2) antagonist PD123319 (50 microg/kg per minute) after candesartan administration abolished the natriuretic/diuretic effects of candesartan in obese rats but not in lean rats. Infusion of AT(2) receptor agonist, CGP-42112A (1 microg/kg per minute), produced greater increase in sodium and urine excretion over basal in obese than in lean rats. The presence of the AT(2) receptor expression in the brush-border and basolateral membranes was confirmed by Western blotting using specific antibody and antigen-blocking peptide. Densitometric analysis of the bands revealed approximately 1.5- to 2.0-fold increase in the AT(2) receptor proteins in both membranes of obese compared with lean rats. Our results suggest upregulation of the AT(2) receptors, which play a role in mediating the natriuretic/diuretic effects of AT(1) receptor blockers in obese Zucker rats. We speculate that AT(2) receptors, by promoting sodium excretion, may protect obese Zucker rats against blood pressure increase associated with sodium and water retention.
机译:最近,人们对研究血管紧张素II 2型(AT(2))受体在病理状态下肾/心血管功能中的作用越来越感兴趣。本研究旨在确定AT(2)受体对利尿/利尿的功能作用,并比较肥胖和瘦Zucker大鼠(12周龄)中管状AT(2)受体的表达水平。在麻醉下,坎地沙坦(1型血管紧张素II型[AT(1)]特异性拮抗剂; 100微克/千克大剂量)与肥胖大鼠相比,肥胖症引起的利尿/利尿作用更大。坎地沙坦给药后的特异性AT(2)拮抗剂PD123319(每分钟50微克/千克)消除了坎地沙坦在肥胖大鼠中的利钠/利尿作用,但在瘦鼠中则没有。与瘦大鼠相比,在肥胖者中,AT(2)受体激动剂CGP-42112A(1微克/千克每分钟)的输注与基础相比,钠和尿的排泄量增加更大。通过使用特异性抗体和抗原封闭肽的蛋白质印迹证实了在刷状边界和基底外侧膜中AT(2)受体表达的存在。带的光密度分析显示,与瘦大鼠相比,肥胖的两个膜中AT(2)受体蛋白的含量增加了约1.5至2.0倍。我们的结果表明,AT(2)受体的上调在肥胖Zucker大鼠中介导AT(1)受体阻滞剂的利钠/利尿作用中发挥作用。我们推测通过促进钠排泄,AT(2)受体可以保护肥胖的Zucker大鼠免受钠和水retention留引起的血压升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号